AGER and metabolic syndrome: High plasma levels of sRAGE have been reported to be associated with a lower incidence of coronary artery disease (CAD) [17], and low plasma levels of sRAGE have been reported in patients with carotid and femoral atherosclerosis as well as those with metabolic syndrome [18].